3DF-26907-80967
2 vaccinations
7 coded responses
24 check-ins
7 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 952 / CA
- Registered
- 2021-06-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-03
Registered in v-safe
-
2021-06-03
Dose 1 — Pfizer-BioNTech
- 2021-06-03
-
2021-06-04
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: GoodFree text: I have RA, stopped my meds for a week per my Rheumatologists suggestion. No flare ups so far.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-06-06
- 2021-06-07
- 2021-06-09
-
2021-06-10
Survey response — day 7, dose 1MedDRA: Sinus disorder — Feeling: Fair · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sinus problemsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-17
-
2021-06-25
Dose 2 — Pfizer-BioNTech
- 2021-06-25
- 2021-06-26
- 2021-06-27
-
2021-06-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-06-30
-
2021-07-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-07-02
- 2021-07-09
-
2021-07-16
Survey response — day 21, dose 2MedDRA: Cough, Dyspnoea, Musculoskeletal stiffness — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Short of breath, stiff neck and coughMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-16
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-23
Survey response — day 28, dose 2MedDRA: Arthralgia, Dyspnoea, Fatigue, Muscular weakness, Neck pain — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fatigue, muscle weakness, shortness of breath and neck and shoulder pain. On 40mg of prednisone a day and MRI scheduled. Possible RA flare-upMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-23
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-24
-
2021-07-24
Call successfulParticipant prefers to complete VAERS report online
- 2021-08-01
- 2021-08-02
-
2021-08-06
Survey response — day 42, dose 2MedDRA: Arthralgia, Fatigue, Hypertension, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: High blood pressure 192/105Extreme fatigue and joint pain · Healthcare visit (other): Appointment is scheduled for the 11thMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-06
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-24
- 2021-11-03
-
2021-12-25
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Fatigue, Peripheral swelling, SARS-CoV-2 test positive, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Shortness of breath, temperature, fatigue, swollen legs and feet. Tested positive for Covid.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-25
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2021-12-27
-
2022-06-26
Survey response — 12 months, dose 2MedDRA: Neuropathy peripheral — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: NeuropathyMedDRA releases: 2024-11 · check-in free text available
-
2022-06-26
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-06-27
Call successfulParticipant prefers to complete VAERS report online
-
2022-06-27
Call successfulParticipant prefers to complete VAERS report online
-
2022-06-27
Call successfulParticipant prefers to complete VAERS report online
-
2022-06-27
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-03 | Pfizer-BioNTech | |
| 2 | 2021-06-25 | Pfizer-BioNTech | No |
Call center
5 call center cases
5 successful
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): I have RA, stopped my meds for a week per my Rheumatologists suggestion. No flare ups so far.
Release 9 — day 7, dose 1
Systemic reaction (other): Sinus problems
Release 9 — day 21, dose 2
Symptoms: Short of breath, stiff neck and cough
Release 9 — day 28, dose 2
Symptoms: Fatigue, muscle weakness, shortness of breath and neck and shoulder pain. On 40mg of prednisone a day and MRI scheduled. Possible RA flare-up
Release 9 — day 42, dose 2
Symptoms: High blood pressure 192/105Extreme fatigue and joint pain
Healthcare visit (other): Appointment is scheduled for the 11th
Release 10 — 6 months, dose 2
Symptoms: Shortness of breath, temperature, fatigue, swollen legs and feet. Tested positive for Covid.
Release 12 — 12 months, dose 2
Symptoms: Neuropathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | · | ✓ |
| SD | Arthralgia | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Hypertension | ✓ | · | ✓ |
| SD | Muscular weakness | ✓ | · | ✓ |
| SD | Musculoskeletal stiffness | ✓ | · | ✓ |
| SD | Neck pain | ✓ | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Sinus disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release